Materialise revenue climbs to €70.1 million
- Materialise reported Q2 2026 revenue of EUR70.1 million, up 8.1% year over year.
- Adjusted EBITDA increased 15.7% to EUR9.6 million, while net profit reached EUR3.3 million.
- The company reported growth in its Medical segment and a net cash position of EUR74.2 million.
Materialise NV (NASDAQ:MTLS) reported second quarter 2026 revenue of EUR70.1 million, up 8.1% year over year, while adjusted EBITDA increased to EUR9.6 million from EUR8.3 million.
The results compared with the prior-year quarter when Materialise reported revenue of EUR64.8 million, while adjusted EBIT increased 26.9% to EUR3.9 million from EUR3.1 million.
Materialise Chief Executive Officer Fried Vancraen said, “our continued focus on innovation and operational execution supported growth across our business segments,” according to the company’s earnings announcement.
The company reported net profit of EUR3.3 million, or EUR0.06 per diluted share, compared with EUR199 thousand, or EUR0.00 per diluted share, in the same period last year, while investing EUR2.9 million in share buybacks during the quarter.
Following the announcement the Materialise share price was not provided in the available earnings release.
For the first half of 2026, Materialise reported revenue of EUR136.3 million, up 3.9% year over year, driven by 9.6% growth in the Materialise Medical segment.
Materialise reported adjusted EBITDA of EUR17.6 million for the first half of 2026, up 22.2% year over year, and ended the period with total cash reserves of EUR133.7 million and a net cash position of EUR74.2 million.
